Skip to content

Ensysce Biosciences, Inc.

ENSC· NasdaqCore metricsCIK 1716947

Pharmaceutical preparations553 peers

Last sale
Nov 12, 2026 · +12.22%
Market cap
$7.63M
19.46M shares
Filings
550
$2.18M
Q3 2026−2.8% FY25 yoy
-$82.11M
Q3 2026N/M FY25 yoy
-$82.50M
Q3 2026N/M FY25 yoy
-$7.93M
FY 2025derived
—
-$4.52
Q3 2026N/M FY25 yoy
$29.67M
Q3 2026+23.1% FY25 yoy
$7.63M
—
1.2×
0.3×
—
—

Twelve months to Sep 30, 2026 · derived

Price

$0.392180.78%$1.6479past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$5.07MFY 2025
$5.21M0FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$5,066,650reported
FY 20242024-12-31$5,210,031reported
FY 20232023-12-31$2,230,520reported
FY 20222022-12-31$2,523,383reported
FY 20212021-12-31$3,531,199reported
FY 20202020-12-31$3,931,209reported

Capital returns

Dividends and buybacks · FY2019 to FY2020
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2020—$184.78M$184.78M—6.22M sh−73.9%—
FY2019—$11.58M$11.58M—23.88M sh−4.5%—

Segments

Products
Revenue by Products, FY2021 to FY2025FY2021MPAR · FY2021 · $2.65MTAAP/OUD · FY2021 · $884.62KFY2022MPAR · FY2022 · $2.01MTAAP/OUD · FY2022 · $516.50KFY2023MPAR · FY2023 · $1.29MTAAP/OUD · FY2023 · $937.28KFY2024MPAR · FY2024 · $3.09MTAAP/OUD · FY2024 · $2.12MFY2025MPAR · FY2025 · $5.07M
LineFY2025ShareChange
MPAR$5.07M100%+64.2%
TAAP/OUD———
Total$5.07M

From the 10-K filed Mar 30, 2026ENSC

Pharmaceutical preparations

Ensysce Biosciences, Inc. is the 188th largest of the 554 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Ensysce Biosciences, Inc. · CIK 1716947 · Engraved from SEC EDGAR